Xpand
-
Biologics
Kuros closes acquisition of Xpand creating a leading commercial-stage orthobiologics company
25 Jan 17 Kuros Biosciences (SIX:KURN) today announced the closing of the all-share strategic acquisition of Xpand Biotechnology B.V. of…
Read More » -
Biologics
Kuros Acquires Xpand to Form Orthobiologics Firm with Bone Graft Substitute
December 19, 2016 Kuros Biosciences is to acquire Xpand Biotechnology by way of a share-swapping deal structured as an exchange…
Read More »